Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,487 USD | -7,67% | -16,44% | -50,14% |
Métier
Nombre d'employés: 7
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 01/01/14 |
Peter Wolfe
DFI | Director of Finance/CFO | 56 | 12/12/22 |
Pablo Guzman
CTO | Chief Tech/Sci/R&D Officer | 74 | 01/01/23 |
Karen Cashmere
PRN | Corporate Officer/Principal | 71 | 12/12/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 01/01/14 |
Robert Finizio
BRD | Director/Board Member | 53 | 01/12/22 |
James Sapirstein
BRD | Director/Board Member | 63 | 05/01/23 |
Gregory Freitag
BRD | Director/Board Member | 62 | 05/01/23 |
Min-Chul Park
BRD | Director/Board Member | 42 | 01/12/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 5 062 | 0 | 0 | 90,21 % |
Action B | 1 | 834 902 | 753 188 ( 90,21 %) | 0 | |
Action C | 0 | 50 | 0 | 0 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-50,14% | 3,41 M | |
+9,42% | 115 Md | |
+11,84% | 106 Md | |
-2,53% | 21,96 Md | |
-14,15% | 21,87 Md | |
-5,29% | 19,21 Md | |
-4,16% | 18,08 Md | |
-38,29% | 17,71 Md | |
+7,99% | 14,32 Md | |
+36,24% | 12,42 Md |
- Bourse
- Actions
- Action ZVSA
- Société ZyVersa Therapeutics, Inc.